Previous Page  12 / 18 Next Page
Information
Show Menu
Previous Page 12 / 18 Next Page
Page Background

Volume 4, Issue 7(Suppl)

J Infect Dis Ther 2016

ISSN: 2332-0877, JIDT an open access journal

Page 58

Skin Diseases & Microbiology 2016

October 03-05, 2016

conferenceseries

.com

October 03-05, 2016 Vancouver, Canada

International Conference on

Infectious Diseases, Diagnostic Microbiology &

Dermatologists Summit on Skin Infections

Direct application of loop mediated isothermal amplification assay for detection of

Mycoplasma bovis

in

mastitic milk

Aqeela Ashraf

University of Veterinary and Animal Sciences, Pakistan

M

ycoplasma

mastitis is always difficult to control due to lack of rapid and accurate diagnostic tool. The diagnostic methods

available are mostly time consuming due to laborious culturing requirement, expensive, non-specific and less sensitive like

biochemical tests and conventional PCR assay. A loop mediated isothermal amplification (LAMP) assay was developed for detection

of

Mycoplasma bovis

(

M. bovis

) directly from clinical mastitic milk samples. The LAMP assay was developed and validated on clinical

samples obtained from

M. bovis

and other mastitis-causing pathogens detected by MALDI-TOF. 3 different sets of primers were

used targeting different gene regions of

M. bovis

. The genes selected were UvrC, 16S rRNA and GyrB region. LAMP conditions were

optimized for each of these and the efficiency, sensitivity and specificity of these LAMP primers were evaluated and compared. The

result of 16S rRNA primers was more sensitive while GyrB primers were more specific. To confirm the specificity of the developed

assay, other bacterial strains used were

Mycoplasma agalactiae, Escherichia coli, Staphylococcus aureus, Streptococcus agalactiae,

Streptococcus dysgalactiae

and

Streptococcus uberis

. No cross reactivity was observed in all of the primer sets. Results were also

compared to conventional PCR assay with primers chosen from the same genes and confirmed by sequencing. For the evaluation of

LAMP assay sensitivity, culture-positive milk samples were subjected to the assay. LAMP assay detected

M. bovis

in some of those

milk samples which were PCR negative. In the present study we have developed, validated and evaluated LAMP assay for detection

of

M. bovis

from mastitis milk samples. The assay is authentic, rapid and sensitive.

aqeelamalik09@gmail.com

Novel T-cell assays for the discrimination of active and latent tuberculosis infection: The diagnostic value

of PPE family

Shima Mahmoudi, Setareh Mamishi

and

Babak Pourakbari

Tehran University of Medical Sciences, Iran

T

he diagnosis of active and latent tuberculosis remains a challenge. Although a new approach based on detecting

Mycobacterium

tuberculosis

-specific T-cells has been introduced, it cannot distinguish between latent infection and active disease. The aim of this

study was to evaluate the diagnostic potential of interleukin-2 (IL-2) as biomarker after specific antigen stimulation with PE35 and

PPE68 for the discrimination of active and latent tuberculosis infection (LTBI). The production of IL-2 was measured in the antigen-

stimulated whole-blood supernatants following stimulation with recombinant PE35 and PPE68. The discrimination performance

(assessed by the area under ROC curve) for IL-2 following stimulation with recombinant PE35 and PPE68 between LTBI and patients

with active TB were 0.837 [95% confidence interval (CI) 0.72-0.97] for LTBI diagnosis and 0.75 (95% CI 0.63-0.89) for active TB

diagnosis, respectively. Applying the 6.4 pg/mL cut-off for IL-2 induced by PE35 in the present study population resulted in sensitivity

of 78%, specificity of 83%, PPV of 83% and NPV of 78% for the discrimination of active TB and LTBI. In addition, a sensitivity of

81%, specificity of 71%, PPV of 68 and 83% of NPV was reported based on the 4.4 pg/mL cut-off for IL-2 induced by PPE68. This

study confirms IL-2 induced by PE35 and PPE68 as a sensitive and specific biomarker and highlights IL-2 as new promising adjunct

markers for discriminating of LTBI and active TB disease.

mahmoudi18033@gmail.com

J Infect Dis Ther 2016, 4:7(Suppl)

http://dx.doi.org/10.4172/2332-0877.C1.018